Nuwacell Biotechnologies Co., Ltd.

9 clinical trials · Sponsor

Record	Firm	Date
A Study of [89Zr]-Oxine-NCR100 Injection for the Cellular Distribution (NCT07139431)	Nuwacell Biotechnologies Co., Ltd.	2025-08-29
A Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of NCR201 in the Treatment of Subjects With Parkinson's Disease (NCT06978920)	Nuwacell Biotechnologies Co., Ltd.	2025-06-06
A Trial to Evaluate the Safety and Efficacy of NCR102 in Subjects With aGVHD (NCT06941350)	Nuwacell Biotechnologies Co., Ltd.	2025-04-28
A Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of NCR101 in the Treatment of Subjects With Interstitial Lung Disease (NCT06825169)	Nuwacell Biotechnologies Co., Ltd.	2025-03-01
A Study of NCR100 Injection for the Treatment of Knee Osteoarthritis（ KOA） (NCT06741098)	Nuwacell Biotechnologies Co., Ltd.	2025-02-20
A Trial to Evaluate the Safety and Efficacy of NCR300 in Preventing Recurrence of Acute Myeloid Leukemia（AML) After Transplantation (NCT06441084)	Nuwacell Biotechnologies Co., Ltd.	2024-06-30
A Trial to Evaluate the Safety and Preliminary Efficacy of iNK in the Treatment of Subjects With Solid Tumor (NCT06245018)	Nuwacell Biotechnologies Co., Ltd.	2024-02-01
A Trial to Evaluate the Safety, Tolerability, and Efficacy of NCR100 Injection in the Treatment of Subjects With KOA (NCT06049342)	Nuwacell Biotechnologies Co., Ltd.	2024-01-25
A Trial to Evaluate the Safety and Efficacy of NK Cells in Subjects With Myelodysplastic Syndromes (NCT05371730)	Nuwacell Biotechnologies Co., Ltd.	2022-05-30

Every clearance here is in the API, with alerts when new ones post.